Chris@NNW, Author at NetworkNewsWire

ThursdayOct 22, 2020 9:44 am

The JBoy Show Talks with Sportswriter Woody Paige

Woody Paige shares memories of growing up as Elvis Presley’s neighbor Tom Brady appears to be nearing end of his NFL career COVID has put temporary end to tailgating Sportswriter and ESPN’s Around the Horn host Woody Paige joined Jake Crain on The JBoy Show’s Sept. 15 episode to discuss Elvis Presley, coaches, tailgating and more. The show began with Paige reminiscing about his childhood when he was the next-door neighbor to Elvis Presley in government housing. He used to sit on the front porch and listen to Presley play guitar, Paige shared. Once he got older, he even joined…

ThursdayOct 22, 2020 9:24 am

InsuraGuest Technologies, Inc. (TSX.V: ISGI) Proprietors Policy Portal Now Open for Business

Launch of InsurTech Portal to Offer Business Owner Liability Protection The Insure the People Portal to Provide Coverage to Over 130 Class Codes Coverage for Building & Business Property and Business Income General Liability Occurrence Limits: US$300,000, US$500,000, US$1 million and US$2 million Employment Practices Liability With the launch of its business owner policy (“BOP”) portal, InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) is extending its general liability coverage to a vital sector of the U.S. economy: small businesses. Through the site—InsureThePeople.com—small business owners and operators of a wide range of enterprises, from public accountants to commodity merchants to bars…

ThursdayOct 22, 2020 9:00 am

In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster

NetworkNewsWire Editorial Coverage: Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery of a blockbuster drug, or a drug that generates more than $1 billion in sales per year, occurs rarely, the tremendous benefits of owning blockbuster therapeutics can mean tens of billions of dollars for a company during the patent-protected life of the drug. It makes sense, then, that pharmaceutical giants are in hot pursuit of what could be the next new drug — and the company that owns…

WednesdayOct 21, 2020 1:06 pm

Mushrooms’ Potential in Functional Foods Market Being Realized by Therapeutics Innovator Rritual Mushrooms

Emerging Wellness Foods Brand Rritual Mushrooms Inc. is developing plant-based superfood products to lead out a fledgling market segment that has a high degree of promise as consumer interest in functional foods increases While the mushroom therapeutics subcategory of products is still new and developing, analysts researching the overall functional foods market expect the industry to grow at a CAGR of 7.9 percent to $275.77 billion between 2019 and 2025 Rritual Mushrooms’ introductory product line draws on the reputations of the Chaga, Lion’s Mane and Reishi mushrooms as beneficial to overall wellness, combining them with herbal remedy adaptogens in powdered…

WednesdayOct 21, 2020 9:28 am

Predictive Oncology Inc. (NASDAQ: POAI) Industry Leader in Growing Precision Medicine Market

Recent study reports CAGR of 9.7% in precision medicine space. Predictive Oncology focused on use of data, artificial intelligence to develop personalized cancer therapies. One of POAI’s primary projects is building multi-omic predictive models of tumor drug response A recent study of the global precision medicine market indicates a bright future for the industry, especially for U.S.-based companies focusing on cancer research, such as Predictive Oncology Inc. (NASDAQ: POAI). The study reported a CAGR of 9.7% in the sector, with North America dominating the market and oncology expected to hold the highest market. “Precision medicine, a combination of molecular biology…

TuesdayOct 20, 2020 12:16 pm

Forget the Crystal Ball, but Look for Untraceable’s Blockchain Futurist Conference to Deliver Insights on Market News Yet to Come

Conference event organizer Untraceable will hold its third annual Blockchain Futurist Conference Nov. 11 and 12 for blockchain enthusiasts, businesses and government policy makers looking forward to shaping their organizations to meet coming trends The Futurist Conference 2020 will be held virtually through an online platform that moves the ball forward despite the COVID pandemic’s ability to hold commerce back this year Registration for the conference will be free and will include the opportunity for raffle prizes and a spot in a fun Internet-crossing scavenger hunt Untraceable has shown its ability to draw world-class industry experts and thought leaders, and…

TuesdayOct 20, 2020 11:50 am

Gage Cannabis Co. Announces Pre-IPO Financing Round, Early Opportunity to Invest in Top Operator

Round of financing led by Bruce Linton, executive chairman of Gage Cannabis and cannabis industry pioneer Reg A+ equity financing offers chance to invest in exclusive cultivator, processor, and retailer of world-leading cannabis brands First step in Gage’s journey to becoming publicly traded company Gage Cannabis Co., the leading high-quality craft cannabis brand and operator in Michigan, has launched a Regulation A, Tier 2, equity financing. The pre-IPO round of financing is being led by Bruce Linton, executive chairman of Gage Cannabis, a founder and former CEO and chairman of Canopy Growth Corp. “We wanted to provide investors with the…

TuesdayOct 20, 2020 9:00 am

Banking on the Next Blockbuster Drug

NetworkNewsWire Editorial Coverage: Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that’s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly called a “blockbuster.” Blockbusters are scarce, but the proverbial quest for blockbuster drugs continues unabated because of vast unmet medical needs and because blockbuster therapeutics can be worth tens of billions of dollars during their patent-protected lives. Little wonder that pharmaceutical giants often buy up…

MondayOct 19, 2020 11:38 am

Pac Roots Cannabis Corp. (PACR) Set to Benefit as Hemp and Cannabis Producers Evolve, Differentiate Crop Cultivation

Pac Roots Cannabis Corp. specializes in creation of unique, proprietary cannabis and hemp strains Following its tie-up with Phenome One Corp, Pac Roots offers over 350 meticulously designed cultivars possessing wide array of characteristics Introduction of patent protection on genetically modified hemp strains along with insurance provided to hemp growers incentivizes hemp production, drives greater demand for genetically modified seeds and cultivars Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis (CSE: PACR) has earned a reputation for operating on the cutting edge of hemp and cannabis cultivation. This foresight in staying…

MondayOct 19, 2020 10:56 am

SRAX Inc. (NASDAQ: SRAX) Spinoff BIGtoken(R) Inc. Announces George Stella as Chief Revenue Officer

George Stella appointed chief revenue officer of BIGtoken following executive vice president tenure at SRAX SRAX moving BIGtoken to separate publicly traded company through definitive share exchange agreement with Force Protection Video Equipment Corp BIGtoken platform compensates over 16 million users for data that marketers access for fee BIGtoken(R) Inc., a former SRAX (NASDAQ: SRAX) division, has appointed SRAX executive vice president George Stella as chief revenue officer of BIGtoken following its transition to a publicly-traded company. BIGtoken is a consumer data management and distribution system empowering brands to unlock the power of data through a transparent platform that rewards…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW